Guillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, Gilles Salles, Michael Wenger, Anna Truppel-Hartmann, and David J. Carlile. 2016. “Rationale for Optimal obinutuzumab/GA101 Dosing Regimen in B-Cell Non-Hodgkin Lymphoma”. Haematologica 101 (2). Pavia, Italy, 226-34. https://doi.org/10.3324/haematol.2015.133421.